Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.47 USD | -0.56% | -4.43% | +10.78% |
04-23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
04-23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.78% | 1.39B | |
+5.06% | 111B | |
+12.16% | 105B | |
-12.94% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-11.18% | 16.96B | |
+4.80% | 13.7B | |
+36.59% | 12.45B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Transcript : Kiniksa Pharmaceuticals, Ltd., Q2 2023 Earnings Call, Jul 25, 2023